ICCC Share Price

Open 5.90 Change Price %
High 6.05 1 Day 0.24 4.13
Low 5.89 1 Week 0.00 0.00
Close 6.05 1 Month -0.06 -0.98
Volume 1756 1 Year -1.57 -20.60
52 Week High 8.24
52 Week Low 0.00
ICCC Important Levels
Resistance 2 6.20
Resistance 1 6.14
Pivot 6.00
Support 1 5.96
Support 2 5.90
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

ImmuCell Corporation (NASDAQ: ICCC)

ICCC Technical Analysis 2
As on 20th Jan 2017 ICCC Share Price closed @ 6.05 and we RECOMMEND Sell for LONG-TERM with Stoploss of 6.62 & Strong Buy for SHORT-TERM with Stoploss of 5.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
ICCC Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ICCC Other Details
Segment EQ
Market Capital 15970388.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.immucell.com
ICCC Address
ICCC
56 Evergreen Drive
Portland, ME 04103
United States
Phone: 207-878-2770
ICCC Latest News
ImmuCell Corporation (NASDAQ:ICCC) Average Rating At 0   Markets Daily   - 18th Jan 17
ImmuCell Corporation (NASDAQ:ICCC) Stock Technicals at Critical Inflection Point   CML News   - 17th Jan 17
ImmuCell Corporation Announces Closing of $3.5 Million Private Placement of ...   Marketwired (press release)   - 21st Oct 16
ImmuCell seeks $3.5 million from private investors to complete new facility   Press Herald   - 18th Oct 16
ImmuCell Breaks Ground for Mast Out(R) Facility   Marketwired (press release)   - 11th Oct 16
ImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations   Marketwired (press release)   - 05th Apr 16
ImmuCell completes $5.9 million public offering   Press Herald   - 04th Feb 16
Portland-based ImmuCell buys recipe for calf medication   Press Herald   - 07th Jan 16
Herd trouble means sales for ImmuCell   Press Herald   - 28th Jun 15
Immucell Corp. ICCC (US: Nasdaq)   Wall Street Journal   - 11th Feb 11
Interactive Technical Analysis Chart ImmuCell Corporation ( ICCC NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ImmuCell Corporation
ICCC Business Profile
ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. The Company�s product, First Defense, is manufactured from cows� colostrum using the Company's vaccine and whey protein purification technologies. The target disease, bovine enteritis (calf scours), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. First Defense is the only USDA-licensed, orally delivered scours preventive product on the market for calves with claims against E. coli K99 and coronavirus (two causes of scours). First Defense provides bovine antibodies that newborn calves need. Wipe Out Dairy Wipes consist of biodegradable towelettes that are pre-moistened with a Nisin to prepare the teat area of a cow in advance of milking.